Weaver Gregory L
SEC-identified person · CIK 1251779 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pharmathene, INC PIP | Chief Financial Officer | filed 2024 - 2026 |
| Atossa Therapeutics, INC. ATOS | Director · Former EVP, CFO, & Director | filed 2013 - 2023 |
| Atai Beckley N.V. ATAI | Chief Financial Officer | filed 2021 - 2022 |
| Sevion Therapeutics, Inc. SVOND | Chief Financial Officer | filed 2017 - 2020 |
| Zyla Life Sciences ZCOR | Director | filed 2014 - 2019 |
| Isolagen INC ILEIQ | Chief Financial Officer | filed 2013 - 2014 |
| Imunon, Inc. clsn | Director · SVP & Chief Financial Officer | filed 2006 - 2013 |
| Poniard Pharmaceuticals, INC. PARD | Chief Financial Officer | filed 2009 - 2010 |
| Scolr Pharma, Inc. SCLR | Director | filed 2007 - 2008 |
| Sirna Therapeutics INC RNAI | Senior Vice President and CFO | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.